JP2010500003A5 - - Google Patents

Download PDF

Info

Publication number
JP2010500003A5
JP2010500003A5 JP2009504513A JP2009504513A JP2010500003A5 JP 2010500003 A5 JP2010500003 A5 JP 2010500003A5 JP 2009504513 A JP2009504513 A JP 2009504513A JP 2009504513 A JP2009504513 A JP 2009504513A JP 2010500003 A5 JP2010500003 A5 JP 2010500003A5
Authority
JP
Japan
Prior art keywords
polypeptide
seq
amino acid
acid sequence
polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009504513A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010500003A (ja
JP5339291B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2007/065992 external-priority patent/WO2008018642A2/en
Publication of JP2010500003A publication Critical patent/JP2010500003A/ja
Publication of JP2010500003A5 publication Critical patent/JP2010500003A5/ja
Application granted granted Critical
Publication of JP5339291B2 publication Critical patent/JP5339291B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009504513A 2006-08-10 2007-08-10 乳癌に関連する遺伝子およびポリペプチド Expired - Fee Related JP5339291B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US83742806P 2006-08-10 2006-08-10
US60/837,428 2006-08-10
US84025006P 2006-08-25 2006-08-25
US60/840,250 2006-08-25
US91502207P 2007-04-30 2007-04-30
US60/915,022 2007-04-30
PCT/JP2007/065992 WO2008018642A2 (en) 2006-08-10 2007-08-10 Genes and polypeptides relating to breast cancers

Publications (3)

Publication Number Publication Date
JP2010500003A JP2010500003A (ja) 2010-01-07
JP2010500003A5 true JP2010500003A5 (https=) 2010-09-24
JP5339291B2 JP5339291B2 (ja) 2013-11-13

Family

ID=38627000

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009504513A Expired - Fee Related JP5339291B2 (ja) 2006-08-10 2007-08-10 乳癌に関連する遺伝子およびポリペプチド

Country Status (8)

Country Link
US (2) US8673548B2 (https=)
EP (1) EP2057187B1 (https=)
JP (1) JP5339291B2 (https=)
KR (1) KR20090064378A (https=)
BR (1) BRPI0716498A2 (https=)
CA (1) CA2660438A1 (https=)
SG (1) SG174071A1 (https=)
WO (1) WO2008018642A2 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005029067A2 (en) 2003-09-24 2005-03-31 Oncotherapy Science, Inc. Method of diagnosing breast cancer
KR20080052570A (ko) 2005-07-29 2008-06-11 타게티드 그로스 인코퍼레이티드 야생형 krp에 의한 활성 사이클린-cdk 복합체 억제의우성 음성 돌연변이 krp 단백질 보호
JP5514453B2 (ja) * 2008-03-04 2014-06-04 株式会社キノファーマ 発光タンパク質を用いたリン酸化酵素阻害物質のスクリーニング方法
EP2275567A1 (en) * 2009-07-15 2011-01-19 Rheinische Friedrich-Wilhelms-Universität Bonn Nucleic acid expression construct and its use as a cell proliferation marker
EP2542155B1 (en) * 2010-03-01 2015-11-04 TAU Therapeutics LLC Method for imaging a disease
US20120131698A1 (en) * 2010-11-12 2012-05-24 Targetd Growth, Inc. Dominant Negative Mutant Kip-Related Proteins (KRP) in Zea Mays and Methods of Their Use
CA2867139A1 (en) 2011-04-11 2012-10-18 Targeted Growth, Inc. Identification and the use of krp mutants in plants
US9062323B2 (en) 2011-04-11 2015-06-23 The Regents Of The University Of California Identification and use of KRP mutants in wheat
JP6014904B2 (ja) * 2011-07-29 2016-10-26 国立大学法人徳島大学 Erap1由来ペプチド及びその使用
CN104066746B (zh) * 2011-10-28 2017-12-05 肿瘤疗法科学股份有限公司 Topk肽及包含它们的疫苗
JP6112569B2 (ja) 2011-12-16 2017-04-12 国立大学法人 東京医科歯科大学 キメラ2重鎖核酸
GB201121924D0 (en) * 2011-12-20 2012-02-01 Fahy Gurteen Labs Ltd Detection of breast cancer
US9903871B2 (en) 2014-07-15 2018-02-27 Temple University Of The Commonwealth System Of Higher Education Stabilized peptide fragments from nucleoredoxin X1 and uses thereof
CN104497147B (zh) * 2014-12-23 2018-07-03 四川大学 一种双受体识别的串联型穿膜肽修饰的肿瘤靶向纳米递药系统
WO2017126461A1 (ja) 2016-01-19 2017-07-27 国立大学法人徳島大学 がん治療用ペプチド及びそれを含む医薬組成物
EP3405579A1 (en) 2016-01-22 2018-11-28 Modernatx, Inc. Messenger ribonucleic acids for the production of intracellular binding polypeptides and methods of use thereof
CN111148752B (zh) 2017-07-19 2024-01-16 国立大学法人德岛大学 肽衍生物和包含其的药物组合物
JP7525855B2 (ja) 2018-11-30 2024-07-31 国立大学法人徳島大学 Big3-phb2相互作用阻害phb2由来ペプチドを含む乳がん治療薬
CN114773480A (zh) * 2022-06-07 2022-07-22 厦门大学附属翔安医院 一种抗topk第32位丝氨酸残基磷酸化的抗体
CN116082447A (zh) * 2022-09-09 2023-05-09 湖南大学 一种多肽及其制备方法
CN117757789A (zh) * 2022-09-26 2024-03-26 领星生物科技(上海)有限公司 用于抑制肿瘤生长的siRNA及其应用
CN120944846A (zh) * 2025-10-15 2025-11-14 北京索莱宝科技有限公司 人PP1α蛋白及其Thr320位点磷酸化蛋白的抗原肽及其抗体的制备方法与应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6656698B1 (en) * 1999-06-30 2003-12-02 Millennium Pharmaceuticals, Inc. 12832, a novel human kinase-like molecule and uses thereof
EP1074617A3 (en) 1999-07-29 2004-04-21 Research Association for Biotechnology Primers for synthesising full-length cDNA and their use
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
EP1425410A2 (en) * 2000-10-03 2004-06-09 Glaxo Group Limited Tumor marker and methods of use
AU2002220265A1 (en) * 2000-11-03 2002-05-15 University Of Vermont And State Agricultural College Compositions for inhibiting grb7
EP1661986A1 (en) 2000-11-17 2006-05-31 Nuvelo, Inc. Nucleic acids and polypeptides enocoded thereby that are member of the kallikrein gene familyNovel nucleic acids and polypeptides
WO2002059271A2 (en) * 2001-01-25 2002-08-01 Gene Logic, Inc. Gene expression profiles in breast tissue
US20030099974A1 (en) * 2001-07-18 2003-05-29 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kits and methods for identification, assessment, prevention, and therapy of breast cancer
WO2003043568A2 (en) 2001-11-15 2003-05-30 The Regents Of The University Of California Compositions and methods for the suppression of mammary epithelial cell proliferation
WO2003064599A2 (en) 2002-01-25 2003-08-07 Origene Technologies, Inc Cancer genes
US6833247B2 (en) * 2002-05-14 2004-12-21 Origene Technologies, Inc. Regulated prostate cancer genes
AU2003217421A1 (en) 2002-02-19 2003-09-09 Idec Pharmaceuticals Corporation Prostate specific genes and the use thereof in design or therapeutics
MXPA05001933A (es) 2002-08-19 2005-04-28 Genentech Inc Composiciones y metodos para el diagnostico y tratamiento de tumores.
CA2500982A1 (en) 2002-09-30 2004-04-15 Oncotherapy Science, Inc. Method for diagnosing testicular seminomas
US6971476B2 (en) * 2003-09-05 2005-12-06 D B Industries, Inc. Safety harness
WO2005029067A2 (en) * 2003-09-24 2005-03-31 Oncotherapy Science, Inc. Method of diagnosing breast cancer
CN101175862A (zh) * 2005-02-10 2008-05-07 肿瘤疗法科学股份有限公司 诊断膀胱癌的方法
WO2006110593A2 (en) 2005-04-07 2006-10-19 Macrogenics, Inc. Biological targets for the diagnosis, treatment and prevention of cancer
EP2311985A1 (en) 2005-07-27 2011-04-20 Oncotherapy Science, Inc. Sirna for treating esophageal cancer
WO2007013575A2 (en) 2005-07-28 2007-02-01 Oncotherapy Science, Inc. Method for diagnosing and treating renal cell carcinoma
PL2201012T3 (pl) * 2007-10-11 2014-11-28 Astrazeneca Ab Pochodne pirolo[2,3-d]pirymidyny jako inhibitory kinazy białkowej b
BRPI0919977A2 (pt) * 2008-10-30 2015-08-25 Oncotherapy Science Inc Derivados de 7-hidróxi-benzoimidazol-4-il-metanona e inibidores de pbk contendo os mesmos

Similar Documents

Publication Publication Date Title
JP2010500003A5 (https=)
Lu et al. A code for RanGDP binding in ankyrin repeats defines a nuclear import pathway
JP4060886B2 (ja) Sh3結合ペプチドの単離および利用
KR101653774B1 (ko) 올리고펩타이드 화합물 및 이의 용도
JP6014904B2 (ja) Erap1由来ペプチド及びその使用
RU2010111120A (ru) Eb13, dlx5, nptx1 и cdkn3 в качестве генов-мишеней для терапии и диагностики рака легкого
Jeong et al. Role of annexin A5 in cisplatin-induced toxicity in renal cells: molecular mechanism of apoptosis
WO1999058675A2 (en) Human genes and gene expression products v
Liu et al. FANCD2 and RAD51 recombinase directly inhibit DNA2 nuclease at stalled replication forks and FANCD2 acts as a novel RAD51 mediator in strand exchange to promote genome stability
JP2010512730A5 (https=)
JP2012501165A5 (https=)
JP2010512730A (ja) 肺癌の腫瘍マーカーおよび治療標的としてのttk
Chen et al. Direct interaction of 14-3-3ζ with ezrin promotes cell migration by regulating the formation of membrane ruffle
Moreno et al. Distinctive interactomes of RNA polymerase II phosphorylation during different stages of transcription
Qu et al. The nuclear localization of SET mediated by impα3/impβ attenuates its cytosolic toxicity in neurons
JP2010523081A5 (https=)
CN108289924A (zh) 阻断组蛋白识别结构域的小分子
US8604163B2 (en) EEF2K assays for identifying compounds that inhibit EEF2K activity
Reimer et al. Phosphorylation of the N-terminal domain regulates subcellular localization and DNA binding properties of the peptidyl-prolyl cis/trans isomerase hPar14
Mandel-Gutfreund et al. ARTS, the unusual septin: structural and functional aspects.
JP6619211B2 (ja) 細胞核輸送受容体kpna2タンパク質に結合するアプタマー、及びそれを用いたkpna2タンパク質の機能阻害
WO2006015084A2 (en) Compositions, kits and assays containing reagents directed to cortactin and an arg/abl protein kinase
CN101050473B (zh) 抗细胞增殖或抗肿瘤药物的筛选试剂盒、筛选方法及用途
RU2011111532A (ru) Твс1d7 в качестве опухолевого маркера и терапевтической мишени в случае злокачественной опухоли
RU2009108274A (ru) Гены и полипептиды, ассоциированные с раком молочной железы